Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol

Company’s first metered-dose inhalation (MDI) product and establishes a new growth vector for the Affordable Medicines ...
PharmTech

Challenges, Innovations, and Future Outlook of Biologics Formulations

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution

Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio-Antibiotic is primarily used for ...
Reuters

US FDA still reviewing Liquidia's inhaled blood pressure drug

Jan 25 (Reuters) - The U.S. Food and Drug Administration is still reviewing Liquidia's (LQDA.O), opens new tab drug to treat a progressive blood vessel disorder related to a lung condition, the ...
Business Wire

Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA ...

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease ...